| Literature DB >> 23517278 |
Giulia Manzini1, Michael Kremer, Philipp Houben, Matthias Gondan, Wolf O Bechstein, Thomas Becker, Gabriela A Berlakovich, Helmut Friess, Markus Guba, Werner Hohenberger, Jan N M Ijzermans, Sven Jonas, Jörg C Kalff, Ernst Klar, Jürgen Klempnauer, Jan Lerut, Hans Lippert, Thomas Lorf, Silvio Nadalin, Björn Nashan, Gerd Otto, Andreas Paul, Jacques Pirenne, Johann Pratschke, Jan Ringers, Xavier Rogiers, Martin K Schilling, Daniel Seehofer, Norbert Senninger, Utz Settmacher, Dirk L Stippel, Karlheinz Tscheliessnigg, Dirk Ysebaert, Heidrun Binder, Peter Schemmer.
Abstract
It remains unclear which liver graft reperfusion technique leads to the best outcome following transplantation. An online survey was sent to all transplant centres (n = 37) within Eurotransplant (ET) to collect information on their technique used for reperfusion of liver grafts. Furthermore, a systematic review of all literature was performed and a meta-analysis was conducted based on patients' mortality, number of retransplantations and incidence of biliary complications, depending on the technique used. Of the 28 evaluated centres, 11 (39%) reported performing simultaneous reperfusion (SIMR), 13 (46%) perform initial portal vein reperfusion (IPR), 1 (4%) performs an initial hepatic artery reperfusion (IAR) and 3 (11%) perform retrograde reperfusion (RETR). In 21 centres (75%), one reperfusion technique is used as a standard, but in only one centre is this decision based on available literature. Twenty centres (71%) said they would agree to participate in randomized controlled trials (RCT) if required. For meta-analysis, IAR vs. IPR, SIMR vs. IPR and RETR vs. IPR were compared. There was no difference between any of the techniques compared. There is no consensus on a preferable reperfusion technique. Available evidence does not help in the decision-making process. There is thus an urgent need for multicentric RCTs.Entities:
Mesh:
Year: 2013 PMID: 23517278 DOI: 10.1111/tri.12083
Source DB: PubMed Journal: Transpl Int ISSN: 0934-0874 Impact factor: 3.782